Barriers to Completing Therapy for Hepatitis C with Direct-Acting Antivirals: A Real-Life Experience from a Single Treatment Center in Egypt

INTRODUCTION: Interferon-based therapies against the hepatitis C virus had a poor adherence profile. On the other hand, new direct-acting antivirals (DAAs) are orally administered medications, show high efficacy against the hepatitis C virus in addition to a high safety profile. Therefore, adherence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Marwa M., O. Shaarawy, Hagar, Anwar, Ismail, Sarhan, Mai D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020227/
https://www.ncbi.nlm.nih.gov/pubmed/33813925
http://dx.doi.org/10.1177/21501327211008051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020227/
https://www.ncbi.nlm.nih.gov/pubmed/33813925
http://dx.doi.org/10.1177/21501327211008051

Ejemplares similares